» Articles » PMID: 35784310

Helios Expression Is Downregulated on CD8 Treg in Two Mouse Models of Lupus During Disease Progression

Overview
Journal Front Immunol
Date 2022 Jul 5
PMID 35784310
Authors
Affiliations
Soon will be listed here.
Abstract

T-cell-mediated autoimmunity reflects an imbalance in this compartment that is not restored by tolerogenic immune cells, e.g., regulatory T cells or tolerogenic dendritic cells (tolDCs). Although studies into T-cell equilibrium have mainly focused on regulatory CD4FoxP3 T cells (CD4 Tregs), recent findings on the lesser known CD8 Tregs (CD44CD122Ly49) have highlighted their non-redundant role in regulating lupus-like disease and their regulatory phenotype facilitated by the transcription factor Helios in mice and humans. However, there are still remaining questions about Helios regulation and dynamics in different autoimmune contexts. Here, we show the absence of CD8 Tregs in two lupus-prone murine models: MRL/MPJ and MRL/lpr, in comparison with a non-prone mouse strain like C57BL/6. We observed that all MRL animals showed a dramatically reduced population of CD8 Tregs and a greater Helios downregulation on diseased mice. Helios induction was detected preferentially on CD8 T cells from OT-I mice co-cultured with tolDCs from C57BL/6 but not in MRL animals. Furthermore, the Helios profile was also altered in other relevant T-cell populations implicated in lupus, such as CD4 Tregs, conventional CD4, and double-negative T cells. Together, these findings could make Helios a versatile maker across the T-cell repertoire that is capable of differentiating lupus disease states.

Citing Articles

Characterization and effective expansion of CD4CD8 TCRαβ T cells from individuals living with type 1 diabetes.

Fajardo-Despaigne J, Lombard-Vadnais F, Pelletier A, Olazabal A, Boutin L, Pasquin S Mol Ther Methods Clin Dev. 2025; 33(1):101400.

PMID: 39877593 PMC: 11772147. DOI: 10.1016/j.omtm.2024.101400.


T Cell Resistance: On the Mechanisms of T Cell Non-activation.

Beckers D, Jainarayanan A, Dustin M, Capera J Immune Netw. 2025; 24(6):e42.

PMID: 39801736 PMC: 11711127. DOI: 10.4110/in.2024.24.e42.


Helios as a Potential Biomarker in Systemic Lupus Erythematosus and New Therapies Based on Immunosuppressive Cells.

Paris-Munoz A, Leon-Triana O, Perez-Martinez A, Barber D Int J Mol Sci. 2024; 25(1).

PMID: 38203623 PMC: 10778776. DOI: 10.3390/ijms25010452.

References
1.
Josefowicz S, Lu L, Rudensky A . Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012; 30:531-64. PMC: 6066374. DOI: 10.1146/annurev.immunol.25.022106.141623. View

2.
Lin S, Chen K, Lin C, Kuo C, Ling Q, Chan C . The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest. 2007; 37(12):987-96. DOI: 10.1111/j.1365-2362.2007.01882.x. View

3.
Liu Y, Deng W, Meng Q, Qiu X, Sun D, Dai C . CD8+iTregs attenuate glomerular endothelial cell injury in lupus-prone mice through blocking the activation of p38 MAPK and NF-κB. Mol Immunol. 2018; 103:133-143. DOI: 10.1016/j.molimm.2018.09.006. View

4.
Mishra S, Liao W, Liu Y, Yang M, Ma C, Wu H . TGF-β and Eomes control the homeostasis of CD8+ regulatory T cells. J Exp Med. 2020; 218(1). PMC: 7527976. DOI: 10.1084/jem.20200030. View

5.
Klarquist J, Zhou Z, Shen N, Janssen E . Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools. Mediators Inflamm. 2016; 2016:5045248. PMC: 4829720. DOI: 10.1155/2016/5045248. View